Background: The prevalence of pulmonary arterial hypertension (PAH) in Saudi adults with sickle cell disease (SCD), the mechanism of its development, and its prospective prognostic significance are unknown.
Background
Sickle cell anemia is an autosomal recessive disorder causing production of abnormal β globin chains, an amino acid substitution in the gene coding for the β chain resulting in the production of HbS rather than HbA. HbA2 and HbF are still produced. The homozygote (SS) has sickle-cell anemia (HbSS), and heterozygotes (HbAS) have sickle-cell trait (Bender & Williams 2012) . Sickle cell disease (SCD) is a health problem in Saudi Arabia, especially in Southern, Western, and Eastern regions where the genes frequency responsible of this disease is quite prevalent with a range of 0.15-0.25. In Al Hassa Governorate, the prevalence of homozygote SCD prevalence ranges from1 to1.5% (Alabdulaali, 2007) . Pulmonary arterial hypertension (PAH), is a syndrome characterized by increased pulmonary vascular resistance and remodeling, and is associated with significant morbidity and mortality, which are directly related to cardiac function (Fisher et al., 2009) . PAH affects approximately 6%-35% of adults with SCD (Gladwin et al., 2004; Ataga et al., 2006; Parent et al., 2011) . In SCD, PAH has been defined by an elevated tricuspid regurgitant jet velocity (TRJV) on trans-thoracic echocardiography (TTE). However, subsequent studies using direct measurement of PASP by right heart catheterization indicate an overestimation of PAH by Trans-thoracic echocardiography (TTE) (Parent et al., 2011) . PAH is associated with markedly increased mortality (Gladwin et al., 2004; Ataga et al., 2006; De Castro et al., 2008) . Some individuals are relatively asymptomatic in the early stages of PAH. PAH is a serious complication of SCD in adults and accounted to affect 32% of adult patients. There are limited data on the prevalence of PAH among adults in Al Hassa region, Saudi Arabia. Factors and patients' characteristics are largely unknown. The definitive diagnosis of PAH is currently established through right-heart catheterization; however, this is an invasive technique and is not suitable for screening. Accurate noninvasive assessment of pulmonary arterial pressure is desirable both for diagnostic purposes and to assess response to therapy (Pashankar et al., 2008) . Trans-thoracic Doppler echocardiography is recommended as the initial noninvasive modality in the screening and evaluation of PAH. Doppler-echocardiogram can be used to measure the velocity of regurgitant blood across the tricuspid valve using the modified Bernoulli's equation to calculate the PASP (Chaudhry et al., 2011) . Estimates of PAH by Doppler echocardiography correlate well with those obtained by cardiac catheterization, moreover, Doppler echocardiography is safe and accurate method to detect PAH especially in children (Colombatti et al 201) . This study aimed to assess the prevalence of PAH among SCD patients attended hematology outpatient clinic at King Fahad Hospital, Al Hassa, Saudi Arabia.
Patients and Methods

Setting and Design
This study included all adults patients with SCD of diverse genetic types including (HbSS, HbSC, HbS/β thalassaemia) attended and admitted to King Fahad Hospital located in Al Hassa, Eastern Province, Kingdom of Saudi Arabia. All patients with SCD (aged > 11 years) are receiving their routine care and management in this hospital through the Hematology clinics and inpatient care during their admission. All patients records were revised using a pre-tested data compilation form to gather information regarding: socio-demographics including age, gender, residence and educational/occupational statuses. Age at diagnosis with SCD symptoms, current management procedures, complications (history and their nature), admission frequency and reasons for these admissions, previous pulmonary problems, intensive care and reasons/frequency, history of pulmonary syndrome. The presence of other comorbid disease conditions (diabetes/bronchial asthma etc.). Laboratory investigations including the disease genotype/fetal hemoglobin, serum ferritin level and other hematological parameters. The results of previous echocardiogram (if any).
Data
End points:
The primary end point was detecting PAH, Secondary points include frequency of admission, acute chest syndrome, Intensive care unit (ICU) admission and mortality related to PAH.
Exclusion criteria: all cases with secondary cause of PAH including:
SCD patients with congenital heart disease or any obstructive heart lesions, collagen vascular disease, HIV, Schistosomiasis, PAH associated with lung disease and or persistent drop in oxygen levels (hypoxia) including; chronic obstructive lung disease (COPD), sleep apnea, pulmonary fibrosis and living at high elevation and pulmonary embolism.
2.2.2 Eligible patients with valid and complete records and with regular compliance and follow up at the hematology clinics were referred after obtaining their (or their legal) guardians' written consent form for Echocardiogram for the diagnosis of PAH.
2.2.3 All patients underwent comprehensive physical examination and thorough history taking followed by Echocardiography to determine TRJV and to calculate PASP. Indices of hemolysis and a laboratory study were also collected to detect varies risk factors possible for the development of PAH.
Data Management and Statistical Analysis
Data entered and analyzed using SPSS version 16.0 (SPSS Inc. Chicago, IL). For categorical data, proportions, frequency and percentage will be used for expression; Chi square and Z test for proportions were used for comparison. Continuous data were expressed using median, mean and standard deviation. Intercorrelation matrix was generated with reporting of correlation coefficient to determine the possible risk factors for the development of PAH in SCD patients. P value < 0.05 considered statistically significant.
Ethical Considerations
Permissions were obtained from King Faisal University as well as from the authorities of King Fahad hospital after approval of the study protocol and data complication form. Written consent forms were obtained from the included patients/their guardians after receiving proper orientations regarding the study objectives and outcome. Data confidentiality was maintained all through the study. Table 1 displays the demographic and clinical characteristics of the included patients with SCD. A total of 202 patients were included females constituted 49.5% (n=100). The age range for the whole sample was 11-74 years (mean=28.80±11.60), females were younger than males but without statistical significance. The table also shows the total hemoglobin level, hemoglobin S; the concentration of total Hb was significantly higher among males (P=0.001). Those with PAH accounted for 37.1% (n=75), more among males but without statistical significance. SPAP showed a mean of 32.7±7.40 mmHg. Those developed acute chest syndrome constituted 23.8 % (n=48), ICU admission was recorded in 90 patients (44.6%) more among males (51.0% vs. 38.0% in females). The frequency of hospital admission also shows no significant difference in relation to gender. The most frequently encountered reason for admission included acute chest syndrome and low hemoglobin concentrations. Overall mortality was 4.0 % and almost 90% of the deaths were due to septic shock. www.ccsen Acute che PAH (sign significant Vol. 5, No. 5; 2013 Consistent with our results, one study has found similar predictors for mortality among SCD with confirmed PAH where mortality was associated with frequent vaso-occlusive crisis and acute chest syndrome (Parent et al., 2011) . Contrary to our results, the previous study found that the hemoglobin level had no role in the development of PAH. In contrast, they observed that in patients with confirmed PAH there was a significantly increased lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) levels, which may also be influenced by liver dysfunction. Compared to studies from the Western countries, our results revealed higher prevalence of PAH and this may be due to the higher prevalence of the disease in Kingdom of Saudi Arabia in Al Hassa region and the unavailability of proper management and early detection of PAH.
Results
Conclusion
The prevalence of PAH among adults Saudis with SCD is higher than that reported from the developed countries. Further assessment using invasive techniques is required coupled employing analytical study design to predict the factors that favor the development of PAH among Saudi patients are required.
